Ann & Robert H Lurie Children's Hospital of Chicago

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Ann & Robert H Lurie Children's Hospital of Chicago sits in the top decile of US sponsors by registered trial count (#185 of 15,742 sponsors by registered trial count).

159 total trials 31 currently recruiting 103 completed early-phase tilt top decile by trial count

Ann & Robert H Lurie Children's Hospital of Chicago: 159 sponsored US clinical trials, 31 recruiting.

Ann & Robert H Lurie Children's Hospital of Chicago sponsors 159 registered US clinical trials on ClinicalTrials.gov, 31 of them currently recruiting, and 103 completed. 5 of these trials are in Phase 3-4 (later-stage) and 29 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Eosinophilic Esophagitis, with 6 trials.

Top-decile sponsor footprint

Ann & Robert H Lurie Children's Hospital of Chicago ranks in the top decile of sponsors by registered trial count (#185 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

C 70/100

103 of 112 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (92.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

159 total, page 2 of 4

COMPLETED NA

Home-based Optimization of Mechanical Ventilation in Children

NCT06055413

COMPLETED NA

Family-Initiated Interpretation in the PICU

NCT05791240

COMPLETED Early Phase 1

Supportive Treatment and Antibiotics for Mild Pediatric Pneumonia

NCT05726253

COMPLETED NA

Project Initiate: Transition to Community Therapy Services After NICU Discharge

NCT05251051

COMPLETED NA

ASPIRES (Activating Cancer Survivors and Their Primary Care Providers to Increase Colorectal Cancer Screening) Study

NCT05084833

COMPLETED Phase 4

Light Therapy for Depression in Adolescent Outpatients

NCT05823090

COMPLETED NA

Pilot Testing PREschooler Care, Community Resources, Advocacy, Referral, Education (PRE-CARE)

NCT04999982

COMPLETED Early Phase 1

Procalcitonin to Reduce Antibiotic Use in Pediatric Pneumonia

NCT04963764

COMPLETED NA

Fertility Decision-Making in Youth and Young Adults

NCT05175170

COMPLETED NA

Suprazygomatic Maxillary Nerve Block in Cleft Palate Outcomes

NCT04909619

COMPLETED Phase 3

Iron Supplementation and Neurodevelopmental Outcome in ELGANs

NCT04691843

COMPLETED

Family Care Conferences Criteria in the Pediatric Intensive Care Unit

NCT04298281

COMPLETED NA

Tiny Cargo, Big Deal! An ED-Based Study of Child Passenger Safety Behaviors

NCT04238247

COMPLETED NA

The Use of A Prebiotic to Promote a Healthy Gut Microbiome in Pediatric Stem Cell Transplant Recipients

NCT04111471

COMPLETED Phase 4

Response of Children With Atopic Dermatitis (Eczema) to Eucrisa

NCT04023084

COMPLETED Phase 1

Safety and Efficacy of a Topical Scalp Treatment for Dry Scalp Conditions in Children and Adult

NCT03830177

COMPLETED

Evaluating the Effects of Kangaroo Care in the NICU

NCT04727125

COMPLETED

Mer-TK in Human Cardiac Cells

NCT04322630

COMPLETED NA

Shadows Edge Mobile Developing Resilience in Adolescent and Young Adult Cancer Survivors

NCT04218682

COMPLETED NA

TODAY! A Mobile App Study

NCT03534167

COMPLETED NA

Adherence to HU and HRQOL in Patients With Sickle Cell Disease: An Intervention Study Using HU-Go App

NCT04675645

COMPLETED

Sickle Cell Pro-Inflammatory Response to Interval Training Study

NCT03653676

COMPLETED

Aerobic Exercise in Boys With Duchenne Muscular Dystrophy (DMD)

NCT03319030

COMPLETED Phase 2

Inhibition of Anaphylaxis by Ibrutinib

NCT03149315

COMPLETED NA

Home-based Assessment of PRO Measures in SCD Using A Smartphone App Platform: A Feasibility Study

NCT04678037

COMPLETED NA

Asthma Inpatient Research on Education

NCT02948738

COMPLETED NA

Infrared Thermography for Assessment of Caudal Block in Children

NCT02907957

COMPLETED NA

Employing eSBI in HIV Testing for At-risk Youth

NCT02703116

TERMINATED Phase 1

Trial of Heat Shock Protein Peptide Complex-96 (HSPPC-96) Vaccine

NCT02722512

COMPLETED NA

Child Life Intervention to Decrease Anxiety in Patients and Caregivers for Outpatient Surgical Intervention

NCT03075059

COMPLETED NA

A Novel Approach to Inpatient Pediatric Physical Activity Measurement - The 6th Vital Sign

NCT03064529

COMPLETED Phase 2

Intravenous Lidocaine for Post-Tonsillectomy Pain in Pediatric Patients

NCT02595463

COMPLETED NA

KingVision Video Laryngoscopy vs Direct Laryngoscopy - Equivalence Trial

NCT02590237

COMPLETED NA

Improving Communication in the PICU: The Navigate Study

NCT02333396

COMPLETED

Early Detection and Management of Bronchiolitis Obliterans Syndrome Following Pediatric Hematopoietic Stem Cell Transplantation

NCT03072849

COMPLETED NA

A Comparison of the Ambu AuraGain Versus LMA Supreme in Children

NCT02380768

COMPLETED NA

Ultrasonography for Confirmation of Caudal Injection

NCT02321787

COMPLETED Phase 2

Magnesium vs Placebo for Tonsillectomy

NCT02218424

COMPLETED NA

Impact of Increased Parent Presence in the Neonatal Intensive Care Unit on Parent & Infant Outcomes

NCT02901665

COMPLETED

Longitudinal Study of Children With Concussions

NCT03415048

COMPLETED NA

Prediction of Excretion and Toxicity of High Dose Methotrexate in Children and Adolescents With ALL

NCT02133599

COMPLETED NA

Assessment of the I-gel and Air-Q Supraglottic Airways as Conduits for Tracheal Intubation in Children

NCT02189590

COMPLETED

Long Term Outcomes in β Thalassemia Major

NCT02307786

COMPLETED NA

Pediatric Heart Transplantation: Transitioning to Adult Care

NCT02090257

COMPLETED NA

A Comparison of Nasal Versus Oral Fiberoptic Intubation in Children

NCT02029300

COMPLETED NA

Comparison of Fiberoptic Intubation With Fiberoptic Intubation Through an Air-Q Intubating Laryngeal Airway in Infants and Small Children

NCT01876940

COMPLETED NA

Comparison of Three Treatments for Lower Extremity Apophysitis

NCT01826071

COMPLETED

Molecular Epidemiology of Clostridium Difficile Infections in Children

NCT01957761

COMPLETED

Effect of Acne Vulgaris on Quality of Life of Teenagers Compared to Parent Perceived Effect on Quality of Life

NCT01835210

COMPLETED NA

A Comparison of the Laryngeal Mask Airway (LMA) - Unique and LMA-Supreme in Children

NCT01653795

← Previous Page 2 of 4 Next →

What is open in the Ann & Robert H Lurie Children's Hospital of Chicago pipeline

31 recruiting of 159 indexed (19% open); 103 completed (65%).

Phase mix: 5 late (III/IV) vs 29 early (I/II) (early-phase heavy).

Top condition: Eosinophilic Esophagitis (6 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Ann & Robert H Lurie Children's Hospital of Chicago: open-pipeline peers nationwide

Peers matched on 159 registered trials and 19% open enrollment, not the therapeutic-area sidebar.

Ann & Robert H Lurie Children's Hospital of Chicago sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 02004006008001,000 0%5%10%15%20%25% Total trials Recruiting share Ann & Robert H Lurie Children's Hospital of ChicagoGalderma R&DPfizer's Upjohn has merged with Mylan to form ViatrisUniversity of South CarolinaAlexion PharmaceuticalsScripps Translational Science InstituteUCB Biopharma SRLUniversity of Texas Southwestern Medical CenterThe University of Texas Health Science Center, Houston
Ann & Robert H Lurie Children's Hospital of Chicago sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Ann & Robert H Lurie Children's Hospital of Chicago sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 159 trials (± recruiting share)

Sponsors near 19% open enrollment (± trial volume)

What to do with this Ann & Robert H Lurie Children's Hospital of Chicago page

159 registered trials is a research-attention snapshot, not an endorsement of Ann & Robert H Lurie Children's Hospital of Chicago or any single study.

  • 31 of Ann & Robert H Lurie Children's Hospital of Chicago's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Eosinophilic Esophagitis is the condition Ann & Robert H Lurie Children's Hospital of Chicago studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Eosinophilic Esophagitis trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Ann & Robert H Lurie Children's Hospital of Chicago pipeline card: 159 registered trials from official public datasets.Report a data error.